Nhật Bản cân nhắc cho phép tiêm kết hợp các vaccine khác nhau

Bộ Y tế Nhật Bản đang cân nhắc khả năng tiêm kết hợp các loại vaccine ngừa COVID-19 khác nhau nhằm giảm bớt quan ngại về nguồn cung và đẩy nhanh chương trình tiêm chủng tại quốc gia này. Chương trình tiêm chủng của Nhật Bản hiện chủ yếu sử dụng vaccine của hãng dược Pfizer và hãng Moderna.

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh